Last reviewed · How we verify
NCT05772481: TEPIREC
Interest of PET-MRI in the Evaluation of the Response After Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
trial testing PET-MRI in Rectal Cancer in 50 participants. Status unknown.
19 September 2025
Quick facts
| Lead sponsor | Institut de cancérologie Strasbourg Europe |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 19 May 2023 |
| Primary completion | 19 September 2025 |
| Estimated completion | 19 September 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- PET-MRI — full drug profile →
Conditions studied
- Rectal Cancer — all drugs for Rectal Cancer →
Sponsor
Institut de cancérologie Strasbourg Europe — full company profile →
Who can join
Adults 18 to 75, any sex, with Rectal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
With 50 patients included, this trial would be the largest pilot study evaluating the value of MRI PET in locally advanced rectal cancer. On the other hand, it would be the only pilot study performing several MRI PET during neoadjuvant treatment. Presumably, the response assessed at the 2nd MRI PET (before cycle 4 or induction chemotherapy) would be predictive of the overall response at the end of neoadjuvant treatment. Then, it would be possible to predict precociously the tumor response.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05772481
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PET-MRI
Trials testing the same drug.
- NCT05390814 — [18F]-Fludarabine PET/MRI in Primary Central Nervous System Lymphoma · Phase 1 · completed
- NCT05263466 — Establishing Radiolabelled PSMA as a Target for Glioma Treatment · NA · not yet recruiting
- NCT03549559 — Imaging Histone Deacetylase in the Heart · NA · recruiting
- NCT03342378 — PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients · completed
- NCT03252990 — 18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability · completed
Other recruiting trials for Rectal Cancer
Currently open trials in the same condition.
- NCT07528209 — Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer · Phase 3 · recruiting
- NCT07537998 — Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a · Phase 2, PHASE3 · recruiting
- NCT07501845 — Registry Maastro Applicator · recruiting
- NCT07369531 — The Impact of Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis on Stoma-free Survival in Low Rectal Anal-pres · NA · recruiting
- NCT07505472 — Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit · Phase 2, PHASE3 · recruiting
Other Institut de cancérologie Strasbourg Europe trials
Trials by the same sponsor.
- NCT06476704 — Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas · Phase 2 · not yet recruiting
- NCT06477939 — Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomi · Phase 3 · not yet recruiting
- NCT06458517 — Evaluation of Two Methods of Administration of Photobiomodulation in the Context of the Prevention and Treatment of Muco · NA · not yet recruiting
- NCT06775119 — Feasibility Study of a Neuromuscular Fatigue Test and Associated Hemodynamic Responses: Application in Healthy Volunteer · NA · completed
- NCT06536556 — Effects of a Single Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: Comparison of Paclitaxel v · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05772481 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut de cancérologie Strasbourg Europe
- Last refreshed: 23 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05772481.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing